Noor Trends News, Technical Analysis, Educational Tools and Recommendations
On Thursday, European stocks climbed as investors awaited key inflation data and scrutinized the minutes of the European Central Bank’s recent meeting, while Basilia Pharmaceuticals saw a surge in shares following US regulatory approval of a new antibiotic.
The European STOXX 600 index edged up 0.1 percent by 0720 GMT, ahead of the release of producer price data for February, scheduled for 0900 GMT.
Economists polled by Reuters anticipated a 8.6 percent decline in the producer price index, remaining unchanged from January.
Later in the day, investors will pore over the minutes of the European Central Bank’s March meeting, seeking clues about the timing of the much-anticipated initial interest rate cut.
Basilia Pharmaceutical Industries experienced a notable 9.4 percent surge, reaching its highest levels in over six months, following approval from the US health sector regulatory authority for its antibiotic Zeftera to treat bacterial infections.
Shares of Compu Group rose by 7.5 percent after receiving an upgraded recommendation from Morgan Stanley for the German medical software company.
